| Literature DB >> 22984327 |
Wondemagegn Mulu1, Gebre Kibru, Getenet Beyene, Meku Damtie.
Abstract
BACKGROUND: Nosocomial infection constitutes a major public health problem worldwide. Increasing antibiotic resistance of pathogens associated with nosocomial infections also becomes a major therapeutic challenge for physicians. Thus, the aim of this study was to identify post operative bacterial infections and determine their current antimicrobial resistance to commonly prescribed drugs.Entities:
Keywords: Bahirdar; Ethiopia; Postoperative infection; clean-contaminated operation
Year: 2012 PMID: 22984327 PMCID: PMC3437975
Source DB: PubMed Journal: Ethiop J Health Sci ISSN: 1029-1857
Postoperative nosocomial infection in relation to sex and age groups of operated patients at FHRH, Bahirdar, October –January, 2010/2011.
| Demographic | Infection status | ||
| Infected | Not infected | Total | |
| Male | 9(9.4) | 87(90.6) | 96(32.7) |
| Female | 23(11.6) | 175(88.4) | 198(67.3) |
| 0–10 | 1(11.1) | 8(88.9) | 9(3.1) |
| 11–20 | 2(5.6) | 34(94.4) | 36(12.2) |
| 21–30 | 18(12.6) | 125(85) | 143(48.6) |
| 31–40 | 2(5.1) | 37(94.9) | 39(13.3) |
| 41–50 | 3(6.7) | 42(93.3) | 45(15.3) |
| >51 | 6(27.3) | 16(72.7) | 22(7.5) |
Nosocomial surgical site and blood stream infections in clean and clean- contaminated operations at FHRH, Bahirdar, October –January, 2010/2011.
| Type of nosocomial | Clean | Clean-contaminated | Total |
| No. (%) | No. (%) | No. (%) | |
| SSI | 1(1.7) | 24(10.3) | 25(8.5) |
| BSI | 0(0) | 2(0.9) | 2(0.7) |
| Both SSI and BSI | 1(1.7) | 4(1.7) | 5(1.7) |
SSI: Surgical site infection; BSI: Blood stream infection
Figure 1Frequency of nosocomial pathogenic bacteria isolates from operated patients at FHRH, Bahirdar, October–January, 2010/2011.
Drug resistance pattern of Gram positive bacteria isolated from nosocomial surgical site and blood stream infections among operated patients, at FHRH, Bahirdar, October – January, 2010/ 2011.
| Organism | Drugs tested | |||||||||||
| CRO | P | AP | AML | E | Ts | CN | NOR | C | CIP | T | D | |
| 7 | 6 | 11 | 8 | 1 | 7 | 6 | 8 | 10 | 5 | 6 | 4 | |
| 4 | 6 | 9 | 5 | 1 | 6 | 4 | 4 | 5 | 4 | 5 | 3 | |
CoNS: Coagulase negative Staphylococcus; CRO: Ceftriaxone; P: Penicillin G; AP: Ampicillin; AML: Amoxicillin; E: Erythromycin Ts: Trimethoprim-sulphamethoxazole; CN: Gentamycin; NOR: Norfloxacin; C: Chloramphenicol;
Drug resistance pattern of Gram negative bacteria isolated from nosocomial surgical site and blood stream infection among operated patients at FHRH, Bahirdar, October–January, 2010/2011.
| Organism | Drugs tested | ||||||||||||
| CRO | AML | AP | Ts | CIP | C | NOR | CN | T | K | NA | F | D | |
| 5 | 8 | 7 | 6 | 4 | 0 | 4 | 4 | 6 | 4 | 6 | 2 | 6 | |
| 5 | 5 | 5 | 3 | 2 | 4 | 1 | 2 | 1 | 3 | 3 | 5 | 4 | |
| 4 | 3 | 4 | 2 | 1 | 3 | 2 | 2 | 2 | 2 | 3 | 3 | 0 | |
| 2 | 1 | 2 | 1 | 0 | 2 | 1 | 2 | 1 | 0 | 1 | 2 | 2 | |
| 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 0 | 1 | 1 | 1 | 1 | |
CRO: Ceftriaxone; AML: Amoxacillin, AP: Ampicillin; Ts: Trimethoprim-sulphamethoxazole; CIP: Ciprofloxacin; C: Chloramphenicol; NOR: Norfloxacin; CN: Gentamycin; T: Tetracycline; K: Kanamycin; NA: Nalidixic Acid; F: Nitrofurantoin; D: Doxycycline.
Antibiogram of bacteria isolated from nosocomial surgical site and blood stream infections at FHRH, Bahirdar, October – January, 2010/ 2011.
| Organism | Antibiogram | |||||||||||
| R2 | R3 | R4 | R5 | R6 | R7 | R8 | R9 | R10 | R11 | R12 | Total | |
| 1 | - | - | 2 | - | 2 | 2 | 1 | 3 | Nt | Nt | 11 | |
| CoNS | 2 | - | 1 | - | 1 | 2 | 1 | - | 2 | Nt | Nt | 9 |
| - | ||||||||||||
| - | 1 | 1 | - | - | 2 | 3 | 1 | - | - | - | 8 | |
| - | - | - | - | - | 1 | 2 | 1 | - | - | 1 | 5 | |
| - | - | - | - | 1 | 1 | - | 1 | 1 | - | - | 4 | |
| - | - | - | - | 1 | - | - | - | - | 1 | - | 2 | |
| - | - | - | - | - | 1 | - | - | - | - | 1 | 2 | |
| - | - | |||||||||||
R2–R12 = number of drugs in which a given isolate is resistant for 2– 12 drugs tested
CoNS = Coagulase negative Staphylococcus, Percentage is calculated for row,
Nt= not tested (Gram positives were tested only for 10 drugs)